Clinical Outcomes of Small-incision Lenticule Extraction (SMILE) Using Vector Planning Method.
1 other identifier
interventional
114
1 country
1
Brief Summary
In the past two decades, the femtosecond laser (FSL) technology has been introduced in the corneal refractive surgery filed, and brought a remarkable innovation. It can make tissue dissection through photodisruption and plasma cavitation. Initially, the FSL was used predominantly to make a corneal flap when performing laser in situ keratomileusis (LASIK), which is followed by stromal ablation using excimer laser. A new surgical technique called femtosecond lenticule extraction (FLEx) has been developed that uses only FSL to dissect two interfaces to create refractive lenticule and then remove it, which is very similar with LASIK. Small incision lenticule extraction (SMILE) which is the advanced form of all-in-one FSL refractive technique does not make a corneal flap rather make small incision where the separated refractive lenticule is removed through, and the upper part of the corneal tissue is called cap. Since the clinical outcomes of SMILE were firstly published in 2011, SMILE has been widely used for correction of myopia or myopic astigmatism worldwide. SMILE provides excellent visual outcomes and has advantages including a lesser decrease in corneal sensitivity and absence of flap related complications compared to LASIK. The vector planning method is newly developed astigmatism correction method, which combines refraction astigmatism in 60 % emphasis and corneal astigmatism in 40 % emphasis. The vectorial difference between corneal astigmatism and refractive cylinder at the corneal plane is ocular residual astigmatism (ORA). In normal eyes treated for myopic astigmatism, the ORA typically ranges from 0.73 to 0.81 D. The eyes with high ORA resulted in inferior clinical outcomes after corneal refractive surgery including LASIK, LASEK, and SMILE. The vector planning method was effective in LASIK according to previous study. Therefore we try to confirm the efficacy of vector planning method in SMILE.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2018
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 16, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 7, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
May 7, 2019
CompletedFirst Submitted
Initial submission to the registry
May 9, 2019
CompletedFirst Posted
Study publicly available on registry
May 13, 2019
CompletedMay 13, 2019
May 1, 2019
9 months
May 9, 2019
May 9, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Uncorrected Distance Vision Acuity at each time point between the two groups.
Uncorrected Distance Vision Acuity in logMAR scale will be compared between the two groups at each time point.
preoperative
Uncorrected Distance Vision Acuity at each time point between the two groups.
Uncorrected Distance Vision Acuity in logMAR scale will be compared between the two groups at each time point.
postoperative 6 months
Corrected Distance vision Acuity at each time point between the two groups.
Corrected Distance Vision Acuity in logMAR scale will be compared between the two groups at each time point.
preoperative
Corrected Distance vision Acuity at each time point between the two groups.
Corrected Distance Vision Acuity in logMAR scale will be compared between the two groups at each time point.
postoperative 6 months
Secondary Outcomes (24)
Total higher order aberration at each time point between the two groups.
preoperative
Total higher order aberration at each time point between the two groups.
postoperative 1 month
Total higher order aberration at each time point between the two groups.
3 months
Total higher order aberration at each time point between the two groups.
6 months
Total higher order aberration changes from baseline at each postoperative time point between the two groups.
preoperative
- +19 more secondary outcomes
Study Arms (2)
manifest refraction planning group
ACTIVE COMPARATORThe subjects underwent SMILE using manifest refraction planning.
vector planning group
ACTIVE COMPARATORThe subjects underwent SMILE using vector planning.
Interventions
The treatments of astigmatism were planned using either the manifest refraction (manifest refraction group) or the vector planning method (vector planning group). The surgery was performed with standardized techniques with triple centration technique using the 500-KHz VisuMax system (Carl Zeiss Meditec AG, Jena, Germany). The superior cap depth was set as 120 µm, and the length of the side cut was set to 2 mm. Once the anterior (upper) and posterior (lower) planes of the lenticule were defined, the anterior and posterior interfaces were dissected using a microspatula with a blunt circular tip and extracted with microforceps. The integrity of the lenticule was assessed subsequently. The treatment plan for the vector planning group involved a combination of refractive astigmatism with 60 % emphasis and corneal astigmatism with 40 % emphasis.
The treatments of astigmatism were planned using either the manifest refraction (manifest refraction group) or the vector planning method (vector planning group). The surgery was performed with standardized techniques with triple centration technique using the 500-KHz VisuMax system (Carl Zeiss Meditec AG, Jena, Germany). The superior cap depth was set as 120 µm, and the length of the side cut was set to 2 mm. Once the anterior (upper) and posterior (lower) planes of the lenticule were defined, the anterior and posterior interfaces were dissected using a microspatula with a blunt circular tip and extracted with microforceps. The integrity of the lenticule was assessed subsequently. The treatment plan for the vector planning group involved a combination of refractive astigmatism with 60 % emphasis and corneal astigmatism with 40 % emphasis.
Eligibility Criteria
You may qualify if:
- \. Age of 20 years or older.
- \. Myopia
- \. Who is willing to get SMILE surgery
You may not qualify if:
- \. Severe ocular surface disease
- \. Any corneal disease, cataract, glaucoma, macular disease, or previous history of intraocular or corneal surgery
- \. Patients with suspicion of keratoconus on corneal topography
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Ophthalmology, Yonsei Univeristy College of Medicine
Seoul, 03722, South Korea
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 9, 2019
First Posted
May 13, 2019
Study Start
August 16, 2018
Primary Completion
May 7, 2019
Study Completion
May 7, 2019
Last Updated
May 13, 2019
Record last verified: 2019-05
Data Sharing
- IPD Sharing
- Will not share